| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue | 133,745 | 167,811 | 165,909 | | Cost of Revenue | 117,770 | 148,248 | 148,150 | | | Gross Profit | 15,975 | 19,563 | 17,759 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 11,591 | 12,375 | 12,872 | | Non Recurring |
-
| 9,299 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 4,383 | (2,111) | 4,886 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 219 | (23) | 282 | | Earnings Before Interest And Taxes | 4,603 | (2,134) | 5,169 | | Interest Expense | 1,711 | 2,667 | 2,574 | | Income Before Tax | 2,892 | (4,801) | 2,595 | | Income Tax Expense | 936 | 1,656 | 896 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,956 | (6,457) | 1,698 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,956 | (6,457) | 1,698 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,956 | ($6,457) | $1,698 |
|
0.29% Nasdaq 
Income Statement
